| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b98f50c2aeb77d855cf723f48384c48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 |
| filingDate |
2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_700c1908089bd54c43cb336869a7b7a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b521f2df4a3a5311bcc440fbf0bf6a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b977dfd2b874f92b9b846ecba93fb538 |
| publicationDate |
2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020079484-A1 |
| titleOfInvention |
Use of egg cellular extract for wound healing |
| abstract |
The present invention provides compositions and methods for the improved healing of chronic wounds. In some embodiments, egg cellular extracts are used to 1) increase expression and/or release by macrohphages of one or more cell mediators selected from the group consisting of IL-1 RA, IL-6, IL-10 and VEGF; 2) decrease expression and/or release by macrophages of one or more cell mediators selected from the group consisting of IL-12, TNF-α, MCP-1, and IL-8; 3) increase expression by macrophages of AMAC-1; 4) promote orientation of macrophage phenotype to an alternatively activated phenotype; and 5) combinations thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I808353-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023146860-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110664724-A |
| priorityDate |
2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |